These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3136460)

  • 1. Repeated exposure of non-human primates to monoclonal antibody and fragments: pharmacokinetic studies and their implications for targeted therapy.
    Lashford LS; Elsom G; Clarke J; Gordon I; Kemshead JT
    Prog Clin Biol Res; 1988; 271():605-17. PubMed ID: 3136460
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the biodistribution of meta-iodobenzylguanidine (mIBG) and the monoclonal antibody UJ13A in patients and animal models.
    Lashford LS; Clarke J; Gordon I; Pritchard J; Kemshead JT
    Prog Clin Biol Res; 1988; 271():643-54. PubMed ID: 3136461
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies: from genes to targeted cancer gene therapy.
    Hawkins RE; Whittington HA; Watkins SJ; Gilham DE
    Gene Ther; 1998 Dec; 5(12):1581-3. PubMed ID: 10023436
    [No Abstract]   [Full Text] [Related]  

  • 6. Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
    Behr TM; Blumenthal RD; Memtsoudis S; Sharkey RM; Gratz S; Becker W; Goldenberg DM
    Clin Cancer Res; 2000 Dec; 6(12):4900-7. PubMed ID: 11156250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody.
    Ramjiawan B; Ariano RE; Mantsch HH; Maiti P; Jackson M
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1317-23. PubMed ID: 12585714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production technologies for monoclonal antibodies and their fragments.
    Andersen DC; Reilly DE
    Curr Opin Biotechnol; 2004 Oct; 15(5):456-62. PubMed ID: 15464378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of recombinant antibody and antibody fragment binding to human thyroglobulin: potential applications in gene therapy.
    Mani JC; Noel D; Marin M; Navarro-Teulon I; Biard-Piechaczyk M; Pau B; Piechaczyk M
    J Mol Recognit; 1998; 11(1-6):117-8. PubMed ID: 10076821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination mechanisms of therapeutic monoclonal antibodies.
    Tabrizi MA; Tseng CM; Roskos LK
    Drug Discov Today; 2006 Jan; 11(1-2):81-8. PubMed ID: 16478695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of genetic engineering on the pharmacokinetics of antibodies.
    Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK
    Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK; Guo HF; Heller G; Cheung IY
    Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
    Cheung NK; Saarinen U; Neely J; Miraldi F; Strandjord S; Warkentin P; Coccia P
    Prog Clin Biol Res; 1985; 175():501-5. PubMed ID: 3991743
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.
    Cheung NK; Kushner BH; Yeh SJ; Larson SM
    Prog Clin Biol Res; 1994; 385():319-28. PubMed ID: 7972227
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of intravenous immunoglobulins.
    Nydegger UE; Mohacsi PJ; Escher R; Morell A
    Vox Sang; 2000; 78 Suppl 2():191-5. PubMed ID: 10938951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
    Cheung NK; Miraldi FD
    Prog Clin Biol Res; 1988; 271():595-604. PubMed ID: 3406022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.